Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.

Lenart BA, Lorich DG, Lane JM.

N Engl J Med. 2008 Mar 20;358(12):1304-6. doi: 10.1056/NEJMc0707493. No abstract available.

2.

More on atypical fractures of the femoral diaphysis.

Lee P, Seibel MJ.

N Engl J Med. 2008 Jul 17;359(3):317; author reply 317-8. No abstract available.

PMID:
18642421
3.

Case reports: two femoral insufficiency fractures after long-term alendronate therapy.

Sayed-Noor AS, Sjödén GO.

Clin Orthop Relat Res. 2009 Jul;467(7):1921-6. doi: 10.1007/s11999-009-0725-x. Epub 2009 Feb 6.

4.

More on atypical fractures of the femoral diaphysis.

Kwek EB, Koh JS, Howe TS.

N Engl J Med. 2008 Jul 17;359(3):316-7; author reply 317-8. doi: 10.1056/NEJMc080861. No abstract available.

5.

Bilateral atypical femoral fractures after long-term alendronate therapy: a case report.

Bamrungsong T, Pongchaiyakul C.

J Med Assoc Thai. 2010 May;93(5):620-4.

PMID:
20524451
6.

A rational approach to management of alendronate-related subtrochanteric fractures.

Das De S, Setiobudi T, Shen L, Das De S.

J Bone Joint Surg Br. 2010 May;92(5):679-86. doi: 10.1302/0301-620X.92B5.22941.

PMID:
20436006
7.

Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium.

Lee JK.

Int J Rheum Dis. 2009 Jul;12(2):149-54. doi: 10.1111/j.1756-185X.2009.01396.x.

PMID:
20374333
8.

Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: clues to the mechanism of increased bone fragility.

Somford MP, Draijer FW, Thomassen BJ, Chavassieux PM, Boivin G, Papapoulos SE.

J Bone Miner Res. 2009 Oct;24(10):1736-40. doi: 10.1359/jbmr.090408.

9.

Spontaneous femoral shaft fracture after long-term alendronate.

Ali T, Jay RH.

Age Ageing. 2009 Sep;38(5):625-6. doi: 10.1093/ageing/afp106. Epub 2009 Jun 25.

PMID:
19556326
10.

Alendronate-related femoral diaphysis fracture--what should be done to predict and prevent subsequent fracture of the contralateral side?

Edwards MH, McCrae FC, Young-Min SA.

Osteoporos Int. 2010 Apr;21(4):701-3. doi: 10.1007/s00198-009-0986-y. Epub 2009 Jun 27. Review.

PMID:
19562241
11.

Atypical femoral fractures bilaterally in a patient receiving denosumab.

Drampalos E, Skarpas G, Barbounakis N, Michos I.

Acta Orthop. 2014 Feb;85(1):3-5. doi: 10.3109/17453674.2013.854668. Epub 2013 Oct 31. No abstract available. Erratum in: Acta Orthop. 2014 Feb;85(1):2.

12.

Bilateral low-energy sequential femoral shaft fractures in patients on long-term bisphosphonate therapy.

Çakmak S, Mahiroğulları M, Keklikçi K, Sarı E, Erdik B, Rodop O.

Acta Orthop Traumatol Turc. 2013;47(3):162-72.

13.

Atypical femoral fractures in patients taking longterm alendronate.

Mulgund M, Beattie KA, Anaspure R, Matsos M, Patel A, Adachi JD.

J Rheumatol. 2011 Dec;38(12):2686-7. doi: 10.3899/jrheum.110725. No abstract available.

PMID:
22134795
14.

Atypical femoral fractures associated with long-term bisphosphonate use.

Chatterjee S.

CMAJ. 2013 Oct 1;185(14):1248. doi: 10.1503/cmaj.121698. Epub 2013 May 6. No abstract available.

15.

A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture.

Cross MB, Nam D, van der Meulen MC, Bostrom MP.

J Bone Joint Surg Br. 2012 Jul;94(7):994-7. doi: 10.1302/0301-620X.94B7.28778.

PMID:
22733959
16.
17.

Non-traumatic fracture of the femoral shaft in a patient taking long-term bisphosphonate therapy.

Ahn JK, Lee J, Cha HS, Koh EM.

Rheumatol Int. 2011 Jul;31(7):973-5. doi: 10.1007/s00296-010-1477-3. Epub 2010 Apr 10. No abstract available.

PMID:
20383511
18.

Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution.

Goh SK, Yang KY, Koh JS, Wong MK, Chua SY, Chua DT, Howe TS.

J Bone Joint Surg Br. 2007 Mar;89(3):349-53.

19.

Insufficiency femoral fractures in patients undergoing prolonged alendronate therapy.

Atik OS, Suluova F, Görmeli G, Yildirim A, Ali AKh.

Eklem Hastalik Cerrahisi. 2010 Apr;21(1):56-9.

20.

[Biphosphonate treatment can cause stress fracture. But treatment benefits significantly overweight the risk].

Sjödén G, Sayed-Noor A, Kadum B, Pettersson U.

Lakartidningen. 2010 Oct 13-19;107(41):2482-3. Swedish. No abstract available.

PMID:
21137565

Supplemental Content

Support Center